TY - JOUR AU - Topalian, S. L. AU - Drake, C. G. AU - Pardoll, D. M. PY - 2015 DA - 2015// TI - Immune checkpoint blockade: a common denominator approach to cancer therapy JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.03.001 DO - 10.1016/j.ccell.2015.03.001 ID - Topalian2015 ER - TY - JOUR AU - Borghaei, H. AU - Paz-Ares, L. AU - Horn, L. AU - Spigel, D. R. AU - Steins, M. AU - Ready, N. E. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced nonsquamous Non-small-cell lung cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1507643 DO - 10.1056/NEJMoa1507643 ID - Borghaei2015 ER - TY - JOUR AU - Brahmer, J. AU - Reckamp, K. L. AU - Baas, P. AU - Crino, L. AU - Eberhardt, W. E. AU - Poddubskaya, E. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced squamous-cell Non-small-cell lung cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504627 DO - 10.1056/NEJMoa1504627 ID - Brahmer2015 ER - TY - JOUR AU - Larkin, J. AU - Chiarion-Sileni, V. AU - Gonzalez, R. AU - Grob, J. J. AU - Cowey, C. L. AU - Lao, C. D. PY - 2015 DA - 2015// TI - Combined nivolumab and ipilimumab or monotherapy in untreated melanoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504030 DO - 10.1056/NEJMoa1504030 ID - Larkin2015 ER - TY - JOUR AU - Postow, M. A. AU - Chesney, J. AU - Pavlick, A. C. AU - Robert, C. AU - Grossmann, K. AU - McDermott, D. PY - 2015 DA - 2015// TI - Nivolumab and ipilimumab versus ipilimumab in untreated melanoma JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1414428 DO - 10.1056/NEJMoa1414428 ID - Postow2015 ER - TY - JOUR AU - Robert, C. AU - Schachter, J. AU - Long, G. V. AU - Arance, A. AU - Grob, J. J. AU - Mortier, L. PY - 2015 DA - 2015// TI - Pembrolizumab versus ipilimumab in advanced melanoma JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1503093 DO - 10.1056/NEJMoa1503093 ID - Robert2015 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - McDermott, D. F. AU - George, S. AU - Hammers, H. J. AU - Srinivas, S. PY - 2015 DA - 2015// TI - Nivolumab versus everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510665 DO - 10.1056/NEJMoa1510665 ID - Motzer2015 ER - TY - JOUR AU - Khoja, L. AU - Maurice, C. AU - Chappell, M. AU - MacMillan, L. AU - Al-Habeeb, A. S. AU - Al-Faraidy, N. PY - 2016 DA - 2016// TI - Eosinophilic fasciitis and acute encephalopathy toxicity from pembrolizumab treatment of a patient with metastatic melanoma JO - Cancer Immunol Res VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-15-0186 DO - 10.1158/2326-6066.CIR-15-0186 ID - Khoja2016 ER - TY - STD TI - Salam S, Lavin T, Turan A. Limbic encephalitis following immunotherapy against metastatic malignant melanoma. BMJ Case Rep 2016;2016. doi:10.1136/bcr-2016-215012. ID - ref9 ER - TY - JOUR AU - Mandel, J. J. AU - Olar, A. AU - Aldape, K. D. AU - Tremont-Lukats, I. W. PY - 2014 DA - 2014// TI - Lambrolizumab induced central nervous system (CNS) toxicity JO - J Neurol Sci VL - 344 UR - https://doi.org/10.1016/j.jns.2014.06.023 DO - 10.1016/j.jns.2014.06.023 ID - Mandel2014 ER - TY - JOUR AU - Derer, A. AU - Frey, B. AU - Fietkau, R. AU - Gaipl, U. S. PY - 2016 DA - 2016// TI - Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors JO - Cancer Immunol Immunother VL - 65 UR - https://doi.org/10.1007/s00262-015-1771-8 DO - 10.1007/s00262-015-1771-8 ID - Derer2016 ER - TY - JOUR AU - Salama, A. K. AU - Postow, M. A. AU - Salama, J. K. PY - 2016 DA - 2016// TI - Irradiation and immunotherapy: From concept to the clinic JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.29889 DO - 10.1002/cncr.29889 ID - Salama2016 ER - TY - JOUR AU - Twyman-Saint Victor, C. AU - Rech, A. J. AU - Maity, A. AU - Rengan, R. AU - Pauken, K. E. AU - Stelekati, E. PY - 2015 DA - 2015// TI - Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer JO - Nature VL - 520 UR - https://doi.org/10.1038/nature14292 DO - 10.1038/nature14292 ID - Twyman-Saint Victor2015 ER - TY - JOUR AU - Park, S. S. AU - Dong, H. AU - Liu, X. AU - Harrington, S. M. AU - Krco, C. J. AU - Grams, M. P. PY - 2015 DA - 2015// TI - PD-1 restrains radiotherapy-induced abscopal effect JO - Cancer Immunol Res VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-14-0138 DO - 10.1158/2326-6066.CIR-14-0138 ID - Park2015 ER - TY - JOUR AU - Pittet, C. L. AU - Newcombe, J. AU - Prat, A. AU - Arbour, N. PY - 2011 DA - 2011// TI - Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis JO - J Neuroinflammation VL - 8 UR - https://doi.org/10.1186/1742-2094-8-155 DO - 10.1186/1742-2094-8-155 ID - Pittet2011 ER - TY - JOUR AU - Gianchecchi, E. AU - Delfino, D. V. AU - Fierabracci, A. PY - 2013 DA - 2013// TI - Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity JO - Autoimmun Rev VL - 12 UR - https://doi.org/10.1016/j.autrev.2013.05.003 DO - 10.1016/j.autrev.2013.05.003 ID - Gianchecchi2013 ER - TY - JOUR AU - Bockle, B. C. AU - Stanarevic, G. AU - Ratzinger, G. AU - Sepp, N. T. PY - 2012 DA - 2012// TI - Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy? JO - Br J Dermatol VL - 167 UR - https://doi.org/10.1111/j.1365-2133.2012.11161.x DO - 10.1111/j.1365-2133.2012.11161.x ID - Bockle2012 ER - TY - STD TI - Menzies AM, Johnson DB, Ramanujam S, Atkinson VG, Wong AN, Park JJ, et al. Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. Ann Oncol. 2017;28:368–76. ID - ref18 ER -